Unlike previous studies, after ruling out other potential genetic drivers, we detected a somatic de novo truncating mutation in the NF1 gene directly in his MTC tumor, and further confirmed the downstream outcome of this mutation at transcriptomic and proteomic levels. This evidence concerns the gene NF1 and neoplasm.